MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study

BACKGROUND: In patients with medulloblastoma, one of the most significant challenges is to reduce the dose of craniospinal irradiation (CSI) to minimize neurological sequelae in survivors. Molecular characterization of patients treated using lower-dose CSI rather than standard therapy is important f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuoka, Kohei, Kurihara, Jun, Mori, Makiko, Arakawa, Yuki, Yoshioka, Ema, Shofuda, Tomoko, Matsushita, Yuko, Hibiya, Yuko, Honda, Satoko, Nakazawa, Atsuko, Kiyotani, Chikako, Kagawa, Naoki, Yamasaki, Kai, Ando, Ryo, Keino, Dai, Miyairi, Yosuke, Akai, Takuya, Kanamori, Masayuki, Ishida, Joji, Park, Young-Soo, Kawamura, Atsufumi, Sasaki, Atsushi, Nishikawa, Ryo, Date, Isao, Nagane, Motoo, Koh, Katsuyoshi, Ichimura, Koichi, Kanemura, Yonehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medulloblastoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165094/
http://dx.doi.org/10.1093/neuonc/noac079.404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165094/
http://dx.doi.org/10.1093/neuonc/noac079.404

Ejemplares similares